David Silberman
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About David Silberman
David Silberman is recorded as CFO at Compugen Ltd (CGEN). Oramed Pharmaceuticals Inc. reported in an 8-K filed May 13, 2024 that David Silberman resigned as Chief Financial Officer, Treasurer and Secretary, effective July 12, 2024. David Silberman has spoken on 5 earnings calls across 1 company, most recently for Compugen Ltd on March 2, 2026.
“On May 10, 2024, David Silberman, the Chief Financial Officer, Treasurer and Secretary (the "CFO") of Oramed Pharmaceuticals Inc. (the "Company"), resigned from his positions with the Company for personal reasons, effective as of July 12, 2024.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2021-07-05–present
-
Current
-
2021-07-05–2024-07-12
-
2021-01-01–2023-05-31
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Oramed Pharmaceuticals Inc.
Other people whose current roles at this company are on record from its filings.
- Nadav Kidron CEO, Board Member
- Avraham Gabay CFO
- Hilla Eisenberg CFO
- Benjamin Shapiro Board Member
- Dr. Arie Mayer Board Member
- Dr. Daniel Aghion Board Member
- Dr. Miriam Kidron Board Member
- Yehuda Reznick Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.